LiveWorld Reports First Quarter 2025 Financial Results
Rhea-AI Summary
LiveWorld (OTC: LVWD) reported its Q1 2025 financial results with total revenues remaining flat at $2.6 million compared to Q1 2024. The company's healthcare segment contributed $2.3 million in revenue. The net loss from operations improved by 45% to $276,000 compared to $498,000 in Q1 2024.
The company's cash position decreased by $1.6 million to $5.0 million, primarily due to timing issues with contract renewals. Accounts receivable significantly increased from $682,000 to $2.3 million. LiveWorld launched its first dedicated AI product, the AI Pharma Brand Reputation Index, in Q1 and plans to release more AI products in beta later this year as part of its increased investment in artificial intelligence initiatives.
Positive
- Net loss from operations improved by 45% year-over-year to $276,000
- Accounts receivable grew significantly from $682,000 to $2.3 million, indicating strong future cash collections
- Successfully launched first AI product (AI Pharma Brand Reputation Index)
- Maintains strong cash position of $5.0 million
Negative
- Flat revenue growth at $2.6 million year-over-year
- Cash burn of $1.5 million in Q1 2025
- Management warns of potential incremental losses due to AI investments
- Net cash decreased by $1.6 million from December 2024
LiveWorld looks to increase its AI investment
CAMPBELL, Calif. and NEW YORK , May 08, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for first quarter 2025.
Three Months 2025 Financial and Business Highlights
- Total three months revenues of
$2.6 million - Healthcare revenues of
$2.3 million in Q1 2025 - Net loss from operations of
$276,000 a reduction of45% when compared to 2024 - Net Cash decreased by
$1.6 million to$5.0 million from December 31, 2024
Management Commentary
“In the first quarter of the 2025 our total revenues were relatively flat when comparing 2024 to 2025, as both were approximately
“For the three months ended March 31, 2025, we saw a cash burn of approximately
“Our focus continues to bring value to our clients through the integration of a human touch with advanced technology,” said Peter Friedman, LiveWorld Chairman & CEO. “To support this vision during 2024 and continuing in 2025 we are expanding our investment in AI. Our first dedicated AI product, the AI Pharma Brand Reputation Index, was launched in Q1. We expect to be in beta for our next generation of AI products later this year.”
Financial Review for the Three Months Ended March 31, 2025
Total revenues were flat when comparing the first quarter of 2025 to 2024. Revenues were approximately
The company reported a net loss for the three months of approximately
The company finished the quarter with approximately
Detailed financial information may be downloaded at www.liveworld.com/ir (LiveWorld’s Investor Relations page) or at https://www.otcmarkets.com/stock/LVWD/overview.
About LiveWorld
LiveWorld is a social-first digital agency and software company that unlocks the full potential of social media to transform customer relationships through integrated compliance, engagement, and insight solutions. We provide brand marketers bold creative rooted in strategy that captivates and resonates, social moderation and engagement that activates interactions, software that enriches customer experiences, and compliance that enables and accelerates digital programs.
With over 29 years of making connections, we leverage our social media DNA to deliver emotion-driven behavior change through digital campaigns with a human touch. LiveWorld clients include the number one brands in pharmaceuticals, healthcare, and financial-travel services. LiveWorld is headquartered in Campbell, California, with an additional office in New York City. Learn more at www.liveworld.com and @LiveWorld.
“Safe Harbor" Statement Under The Private Securities Litigation Reform Act
This press release may contain forward-looking information concerning LiveWorld plans, objectives, future expectations, forecasts and prospects. These statements may include those regarding LiveWorld’s current or future financial performance including but not limited to lists of clients, revenue and profit, use of cash, investments, relationships and the actual or potential impact of stock option expense, and the results of its product development efforts. Actual results may differ materially from those expressed in the forward- looking statements made as a result of, among other things, final accounting adjustments and results, LiveWorld’s ability to attract new clients and preserve or expand its relationship with existing clients, LiveWorld’s ability to retain and attract high quality employees, including its management staff, the ability to deliver new innovative products in a timely manner, changing accounting treatments, and other risks applicable to the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and the Company undertakes no obligation to update these forward-looking statements to reflect subsequent events or circumstances.
LiveWorld Contacts
IR Contact:
David Houston
LiveWorld
dhouston@liveworld.com
(408) 615-8496
PR Contact:
Matthew Hammer
LiveWorld
mhammer@liveworld.com
(737) 212-9739
| LIVEWORLD, INC. | |||||||
| UNAUDITED CONDENSED BALANCE SHEETS | |||||||
| (In thousands, except share data) | |||||||
| March 31, | December 31, | ||||||
| 2025 | 2024 | ||||||
| ASSETS | |||||||
| Current assets | |||||||
| Cash and cash equivalent | $ | 5,045 | $ | 6,603 | |||
| Accounts receivable, net | 2,342 | 682 | |||||
| Prepaid expenses | 461 | 290 | |||||
| Total current assets | 7,848 | 7,575 | |||||
| Property and equipment, net | 31 | 33 | |||||
| Other assets | 27 | 27 | |||||
| Total assets | $ | 7,906 | $ | 7,635 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities | |||||||
| Accounts payable | $ | 213 | $ | 182 | |||
| Accrued employee expenses | 581 | 1,068 | |||||
| Other accrued liabilities | 337 | 413 | |||||
| Deferred revenue | 1,860 | 860 | |||||
| Total current liabilities | 2,991 | 2,523 | |||||
| Total liabilities | 2,991 | 2,523 | |||||
| Stockholders' equity | |||||||
| Common stock: | 34 | 34 | |||||
| Additional paid-in capital | 144,530 | 144,451 | |||||
| Accumulated deficit | (139,649 | ) | (139,373 | ) | |||
| Total stockholders' equity | 4,915 | 5,112 | |||||
| Total liabilities and stockholders' equity | $ | 7,906 | $ | 7,635 | |||
| LIVEWORLD, INC. | |||||||
| CONDENSED STATEMENT OF OPERATIONS | |||||||
| (In thousands, except per share data) | |||||||
| Three Months Ended March 31, | |||||||
| 2025 | 2024 | ||||||
| Total revenues | $ | 2,575 | $ | 2,572 | |||
| Cost of revenues | 1,514 | 1,577 | |||||
| Gross Margin | 1,061 | 995 | |||||
| Operating Expense | |||||||
| Product development | 275 | 272 | |||||
| Sales and marketing | 440 | 510 | |||||
| General and administrative | 638 | 711 | |||||
| Total operating expense | 1,353 | 1,493 | |||||
| Income from operations | (292 | ) | (498 | ) | |||
| Income before tax | (292 | ) | (498 | ) | |||
| Other Income | 17 | 1 | |||||
| Provision for income taxes | (1 | ) | 1 | ||||
| Net income from operations | (276 | ) | (498 | ) | |||
| Earnings per share analysis from operations: | |||||||
| Basic income per share | $ | (0.01 | ) | $ | (0.01 | ) | |
| Shares used in computing basic loss per share | 45,633,442 | 45,633,442 | |||||
| Diluted net income (loss) per share | $ | (0.01 | ) | $ | (0.01 | ) | |
| Shares used in computing diluted income (loss) per share | 45,633,442 | 45,633,442 | |||||
| Departmental allocation of stock-based compensation: | |||||||
| Cost of revenues | $ | 20 | $ | 18 | |||
| Product development | 5 | 5 | |||||
| Sales and marketing | 8 | 8 | |||||
| General and administrative | 46 | 45 | |||||
| Total stock-based compensation | $ | 79 | $ | 76 | |||
| LIVEWORLD, INC. | |||||||
| CONDENSED STATEMENTS OF CASH FLOWS | |||||||
| (In thousands) | |||||||
| Three Months Ended March 31, | |||||||
| 2025 | 2024 | ||||||
| Cash flows from operating activities: | |||||||
| Net income (loss) | $ | (276 | ) | $ | (498 | ) | |
| Adjustments to reconcile net income (loss) provided by (used in) operating activities: | |||||||
| Depreciation of long-lived assets | 6 | 6 | |||||
| Stock-based compensation | 79 | 76 | |||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | (1,660 | ) | (562 | ) | |||
| Other assets | (171 | ) | (124 | ) | |||
| Accounts payable | 31 | (2 | ) | ||||
| Accrued liabilities | (563 | ) | (214 | ) | |||
| Deferred revenue | 1,000 | 1,004 | |||||
| Net cash provided by (used in) operating activities | (1,554 | ) | (314 | ) | |||
| Cash flows from investing activities: | |||||||
| Purchase of property and equipment | (4 | ) | (5 | ) | |||
| Net cash provided by (used in) investing activities | (4 | ) | (5 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from exercise of stock options | ---- | ---- | |||||
| Net cash provided by (used for) financing activities | ---- | ---- | |||||
| Change in cash and cash equivalent | (1,558 | ) | (319 | ) | |||
| Cash and cash equivalents, beginning of period | 6,603 | 4,635 | |||||
| Cash and cash equivalents, end of period | $ | 5,045 | $ | 4,316 | |||
| Supplemental disclosure of non-cash financing and investing activities: | |||||||
| Income tax paid | $ | 1 | $ | 1 | |||